|
 |
 |
 |
 |
 |
| 303 |
NANOG ³í¹®ÀÌ accept µÇ¾ú½À´Ï´Ù ~ [2] |
¹é±¤Çö |
2016/12/09 |
5255 |
 |
| 302 |
Àú³Î ÆíÁýÀå°ü·Ã ±â»ç |
¹é±¤Çö |
2016/09/02 |
21544 |
 |
| 301 |
¿Ü±¹ Àú³ÎÀÇ Editor-in-Chief µÇ´Ù.. |
¹é±¤Çö |
2016/08/17 |
5532 |
 |
| 300 |
2016³â Çкλý ¿¬±¸ÇÁ·Î±×·¥ |
¹é±¤Çö |
2016/06/03 |
5386 |
 |
| 299 |
Á¤ÇöÀÌ ³í¹® accept µÇ¾ú½À´Ï´Ù.. |
¹é±¤Çö |
2016/05/09 |
5478 |
 |
| 298 |
USP11°ú USP19 ³í¹® ±â»ç ¸ðÀ½ |
¹é±¤Çö |
2016/04/28 |
49752 |
 |
| 297 |
ÀÓ±âȯ ¹Ú»ç USP19 ³í¹®ÀÌ Oncotarget¿¡ ¶Ç accept µÇ¾ú½À´Ï´Ù ~ [1] |
¹é±¤Çö |
2016/03/28 |
9650 |
 |
| 296 |
¼º°øÇÑ °úÇÐÀÚ 10°¡Áö ½À°ü |
¹é±¤Çö |
2016/03/15 |
10011 |
 |
| 295 |
"´Ü¹éÁúºÐÇØÁ¶Àý È¿¼Ò ¿¬±¸ °ü½É ÇÊ¿äÇÕ´Ï´Ù~" |
¹é±¤Çö |
2016/02/16 |
22803 |
 |
| 294 |
Journal of Molecular Medicine (IF: 5.107) ÆíÁýÀ§¿ø °ü·Ã ¾ð·Ð º¸µµ |
¹é±¤Çö |
2016/02/12 |
21427 |
 |
| 293 |
Mgl-1 ÀÓ±âȯ ¹Ú»ç ³í¹®ÀÌ Oncotarget¿¡ accept µÇ¾ú½À´Ï´Ù ~ |
¹é±¤Çö |
2016/02/01 |
5679 |
 |
| 292 |
¿ÃÇØ ¸¶Áö¸· ³í¹®ÀÌ Accept µÇ¾ú½À´Ï´Ù ~ |
¹é±¤Çö |
2015/12/30 |
5508 |
 |
| 291 |
2015³â ¿ì¸® ¿¬±¸½Ç 10´ë ´º½º... |
¹é±¤Çö |
2015/12/24 |
5500 |
 |
| 290 |
¶õÀÌÀÇ ±¹Á¦°øµ¿ÇÐȸ ¡®ÃÖ¿ì¼ö ±¸¿¬ ¹ßÇ¥»ó¡¯ ¼ö»ó |
¹é±¤Çö |
2015/12/22 |
5939 |
 |
| 289 |
¶õÀ̰¡ Best Oral Presentation Award¸¦ ¼ö»óÇß½À´Ï´Ù ~ |
¹é±¤Çö |
2015/12/03 |
5912 |
 |
| 288 |
USP37 ³í¹® ±â»ç¸ðÀ½ |
¹é±¤Çö |
2015/11/03 |
22040 |
 |
| 287 |
USP37 ³í¹®ÀÌ Oncotarget Àú³Î¿¡ accept µÇ¾ú½À´Ï´Ù |
¹é±¤Çö |
2015/08/27 |
5648 |
 |
| 286 |
ÀÓ±âȯ ¹Ú»çÀÇ Nucleolin ³í¹® ±â»ç ¸ðÀ½ |
¹é±¤Çö |
2015/08/12 |
112085 |
 |
| 285 |
´ëÇѾÏÇÐȸ ¿ì¼ö¿¬Á¦»ó ¼ö»ó °ü·Ã ¾ð·Ð ¼Ò°³ |
¹é±¤Çö |
2015/07/13 |
10273 |
 |
| 284 |
±âȯÀÌ ³í¹®ÀÌ accept µÇ¾ú½À´Ï´Ù~ [1] |
¹é±¤Çö |
2015/07/10 |
5436 |